June 6 (Reuters) - Contract research company Albany Molecular Research Inc said on Tuesday it would be bought by private equity firms Carlyle Group LP and GTCR LLC for about $922 million in cash.
Albany Molecular Research's stockholders will receive $21.75 for each share they hold, representing a premium of about 10 percent to the stock's Monday close.
No comments:
Post a Comment